Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
about
Sepsis and disseminated intravascular coagulationCauses and consequences of coagulation activation in sepsis: an evolutionary medicine perspectiveHemostatic abnormalities in critically ill patients.Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.The efficacy and safety of different anticoagulants on patients with severe sepsis and derangement of coagulation: a protocol for network meta-analysis of randomised controlled trials.Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis.Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.
P2860
Q26751555-FA0B1C94-EE07-4C7A-8E63-53FDFF379882Q26995417-C660CE0F-DC18-43E2-8FC6-47512AD6DD53Q33419474-3AD6A5D9-B3BA-403A-AF93-FA10196983C7Q35091715-DC16A7F0-516B-4EDA-A6DA-4560D3F98655Q35107098-4D7E5393-166F-4D56-A810-847ED0B1FA88Q35532746-14F1FAA9-B6A9-4823-BFED-44FA1A90E275Q37697849-372452B8-A9A9-429F-9BEE-AD8C241A7B8AQ38640508-CBE6FFBD-355D-4D82-A21F-F79570402E80Q39780897-0DC33C02-16E4-4635-9424-DF9CB18C7994Q40901166-FA1F0ECD-1476-425F-B729-DE23C54AE38EQ43464051-135AE8BD-7D63-4301-9D75-ECCBB6AFA4CEQ48516198-4B820959-9CA5-4266-AF7F-9385D8EB6550
P2860
Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@ast
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@en
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@nl
type
label
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@ast
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@en
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@nl
prefLabel
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@ast
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@en
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@nl
P2093
P2860
P1433
P1476
Efficacy and bleeding risk of ...... agulation: a secondary survey.
@en
P2093
Daizoh Saitoh
Hideo Wada
Hidesaku Asakura
Toshiaki Iba
P2860
P2888
P356
10.1186/S13054-014-0497-X
P577
2014-09-15T00:00:00Z